Localised proton spectroscopy and spectroscopic imaging in cerebral gliomas, with comparison to positron emission tomography
暂无分享,去创建一个
R. L. Kamman | A. M. J. Paans | J. Pruim | J. Pruim | M. Heesters | K. Go | W. Vaalburg | A. Paans | R. Kamman | E. Mooyaart | K. G. Go | E. L. Mooyaart | M. A. A. M. Heesters | W. Vaalburg
[1] A. Ruifrok,et al. Non‐invasive In Vivo localized 1H spectroscopy of human astrocytoma implanted in rat brain: Regional differences followed in time , 1991, NMR in biomedicine.
[2] P A Bottomley,et al. Human in vivo NMR spectroscopy in diagnostic medicine: clinical tool or research probe? , 1989, Radiology.
[3] J Hennig,et al. Human brain tumors: assessment with in vivo proton MR spectroscopy. , 1993, Radiology.
[4] W. Vaalburg,et al. Radiation-induced inhibition of tumor growth as monitored by PET using L-[1-11C]tyrosine and fluorine-18-fluorodeoxyglucose. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[5] G Friedmann,et al. Human brain tumors: spectral patterns detected with localized H-1 MR spectroscopy. , 1992, Radiology.
[6] J. Olesen,et al. Localized in vivo proton spectroscopy in the brain of patients with multiple sclerosis , 1991, Magnetic resonance in medicine.
[7] J. Pruim,et al. Contribution of Magnetic Resonance Spectroscopic Imaging and L-[1-11C]Tyrosine Positron Emission Tomography to Localization of Cerebral Gliomas for Biopsy , 1994 .
[8] F. Yatsu,et al. ACETATE METABOLISM IN THE NERVOUS SYSTEM. N‐ACETYL‐l‐ASPARTIC ACID AND THE BIOSYNTHESIS OF BRAIN LIPIDS * , 1966, Journal of neurochemistry.
[9] J. Frahm,et al. Noninvasive differentiation of tumors with use of localized H-1 MR spectroscopy in vivo: initial experience in patients with cerebral tumors. , 1989, Radiology.
[10] R. Brooks,et al. Correlation of experimental and clinical studies of metabolism by PET scanning. , 1984, Progress in experimental tumor research.
[11] K. Hamacher,et al. Efficient stereospecific synthesis of no-carrier-added 2-[18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution. , 1986, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[12] J. Frahm,et al. Cerebral metabolism in man after acute stroke: New observations using localized proton NMR spectroscopy , 1989, Magnetic resonance in medicine.
[13] J. Pruim,et al. Contribution of magnetic resonance spectroscopic imaging and L-[1-11C]tyrosine positron emission tomography to localization of cerebral gliomas for biopsy. , 1994, Neurosurgery.
[14] G B Matson,et al. Human brain infarction: proton MR spectroscopy. , 1992, Radiology.
[15] David Hilton-Jones,et al. BIOCHEMICAL INVESTIGATION OF HUMAN TUMOURS IN VIVO WITH PHOSPHORUS-31 MAGNETIC RESONANCE SPECTROSCOPY , 1986, The Lancet.
[16] J. Cooper,et al. METABOLISM OF THE ASPARTYL MOIETY OF N‐ACETYL‐l‐ASPARTIC ACID IN THE RAT BRAIN , 1972, Journal of neurochemistry.
[17] W. Vaalburg,et al. Carbon-11 labelled tyrosine to study tumor metabolism by positron emission tomography (PET) , 2004, European Journal of Nuclear Medicine.
[18] K. Go. Cerebral pathophysiology : an integral approach with some emphasis on clinical implications , 1991 .
[19] G Di Chiro,et al. Prediction of survival in glioma patients by means of positron emission tomography. , 1985, Journal of neurosurgery.
[20] N. M. Alpert,et al. Measurement of Brain pH Using 11CO2 and Positron Emission Tomography , 1984, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[21] J. Pruim,et al. Cystic lesions of the brain. A classification based on pathogenesis, with consideration of histological and radiological features. , 1993, European journal of radiology.
[22] P R Luyten,et al. Metabolic imaging of patients with intracranial tumors: H-1 MR spectroscopic imaging and PET. , 1990, Radiology.
[23] K. Ishiwata,et al. In vivo assessment of 6-deoxy-6-[18F]fluoro-D-galactose as a PET tracer for studying galactose metabolism. , 1989, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.
[24] O. Warburg. On the origin of cancer cells. , 1956, Science.
[25] J A Frank,et al. Metabolism of human gliomas: assessment with H-1 MR spectroscopy and F-18 fluorodeoxyglucose PET. , 1990, Radiology.
[26] D. Thomas,et al. Studies on Regional Cerebral pH in Patients with Cerebral Tumours Using Continuous Inhalation of 11CO2 and Positron Emission Tomography , 1986, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[27] P. W. Hochachka,et al. Protons and anaerobiosis. , 1983, Science.
[28] M. Heesters,et al. Localized proton spectroscopy of inoperable brain gliomas. Response to radiation therapy , 1993, Journal of Neuro-Oncology.
[29] M. Itoh,et al. Tumor uptake study of 18F-labeled N-acetylneuraminic acids. , 1990, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.
[30] B. Tunggal,et al. In vivo 13c nuclear magnetic resonance investigations of choline metabolism in rabbit brain , 1990, Magnetic resonance in medicine.
[31] Barry H. Smith,et al. Regulation of hexokinase in cultured gliomas. , 1985, Neurosurgery.
[32] T. Yoshimoto,et al. Intratumoral oxygen pressure in malignant brain tumor. , 1991, Journal of neurosurgery.
[33] G. Cruickshank,et al. Peri-tumoural hypoxia in human brain: peroperative measurement of the tissue oxygen tension around malignant brain tumours. , 1994, Acta neurochirurgica. Supplementum.
[34] William H. Oldendorf,et al. N-Acetyl-L-Aspartic acid: A literature review of a compound prominent in 1H-NMR spectroscopic studies of brain , 1989, Neuroscience & Biobehavioral Reviews.
[35] E. Shoubridge,et al. Proton and phosphorus magnetic resonance spectroscopy of human astrocytomas in vivo. Preliminary observations on tumor grading , 1990, NMR in biomedicine.